Snapshot · Russell 3000 · generated 2026-09-19 21:52 UTC
BCRX — BioCryst Pharmaceuticals, Inc.
UNDERVALUED (MOS +87.6%) · Quality 55/100
Price
8.68
Intrinsic value
69.99
Margin of safety
+87.6%
Implied growth (reverse DCF)
-11.1%
model assumes +16.0%
Value Score
43.4
Quality
55
Psychology
15
Discovery
34.5
price/volume attention only
Moat score
74.2
erosion: none
Value Score: top 28% of Russell 3000 · Quality: top 46%
Open the interactive Deep Dive for BCRX →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/BCRX - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is BCRX undervalued?
As of 2026-09-19, BCRX trades at 8.68 against a computed intrinsic value of 69.99 (+87.6% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.
What is BioCryst Pharmaceuticals, Inc.'s Value Score?
BioCryst Pharmaceuticals, Inc.'s Value Score is 43.4 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.